Alphatec Holdings, Inc. (ATEC) EPS Estimated At $-0.12

July 21, 2018 - By Elena Maslow

Alphatec Holdings, Inc. (NASDAQ:ATEC) Logo

Analysts expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to report $-0.12 EPS on August, 9.They anticipate $0.20 EPS change or 62.50 % from last quarter’s $-0.32 EPS. After having $-0.09 EPS previously, Alphatec Holdings, Inc.’s analysts see 33.33 % EPS growth. The stock increased 2.12% or $0.06 during the last trading session, reaching $2.89. About 64,695 shares traded. Alphatec Holdings, Inc. (NASDAQ:ATEC) has risen 93.60% since July 21, 2017 and is uptrending. It has outperformed by 81.03% the S&P500.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. The company has market cap of $122.48 million. The Company’s product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. It currently has negative earnings. The firm offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems.

Another recent and important Alphatec Holdings, Inc. (NASDAQ:ATEC) news was published by Nasdaq.com which published an article titled: “Alphatec to Report Second Quarter 2018 Financial Results on August 2, 2018” on July 09, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.